• Table of Contents

  • Pharmacokinetics of Drostanolone: Absorption, Distribution, Metabolism, Excretion
  • Absorption
  • Distribution
  • Metabolism
  • Excretion
  • Real-World Examples
  • Expert Opinion
  • References

Pharmacokinetics of Drostanolone: Absorption, Distribution, Metabolism, Excretion

Drostanolone, also known as Masteron, is a synthetic anabolic androgenic steroid (AAS) that is commonly used in the world of sports and bodybuilding. It is known for its ability to enhance muscle growth, strength, and performance. However, like all AAS, drostanolone has a complex pharmacokinetic profile that determines its effectiveness and potential side effects. In this article, we will delve into the absorption, distribution, metabolism, and excretion of drostanolone, providing a comprehensive understanding of its pharmacokinetics.

Absorption

When administered orally, drostanolone has poor bioavailability due to its high first-pass metabolism in the liver. This means that only a small percentage of the drug reaches the systemic circulation and is available for its intended effects. Therefore, most users prefer to administer drostanolone through intramuscular injection, which bypasses the liver and allows for a higher bioavailability.

Once injected, drostanolone is rapidly absorbed into the bloodstream and reaches peak plasma concentrations within 2-3 days. This fast absorption rate is due to the drug’s high lipophilicity, meaning it has a strong affinity for fat cells. This also explains why drostanolone is often used in cutting cycles, as it can help reduce body fat levels.

Distribution

After absorption, drostanolone is distributed throughout the body, with a high affinity for androgen receptors in muscle tissue. This is where the drug exerts its anabolic effects, promoting protein synthesis and muscle growth. However, drostanolone also has a high affinity for androgen receptors in the scalp, which can lead to hair loss in some users.

Another important factor in the distribution of drostanolone is its binding to sex hormone-binding globulin (SHBG). This protein binds to sex hormones, including testosterone and drostanolone, and regulates their availability in the body. Drostanolone has a high affinity for SHBG, which can lead to a decrease in free testosterone levels. This can have negative effects on libido and sexual function.

Metabolism

Once distributed throughout the body, drostanolone undergoes extensive metabolism in the liver. The primary metabolites of drostanolone are 2α-methyl-dihydrotestosterone (2α-Me-DHT) and 2β-methyl-dihydrotestosterone (2β-Me-DHT). These metabolites are less potent than drostanolone itself, but they still contribute to its anabolic effects.

One of the unique characteristics of drostanolone is its resistance to aromatization, the process by which testosterone is converted into estrogen. This means that drostanolone does not have estrogenic side effects, such as water retention and gynecomastia. However, it also means that drostanolone does not have any estrogenic benefits, such as improved bone density and cholesterol levels.

Excretion

After metabolism, drostanolone and its metabolites are excreted from the body primarily through the urine. The half-life of drostanolone is approximately 2-3 days, meaning it takes this amount of time for half of the drug to be eliminated from the body. However, the detection time of drostanolone in urine can be much longer, up to 3-4 weeks, due to the presence of its metabolites.

It is important to note that the excretion of drostanolone can be affected by various factors, such as age, liver and kidney function, and hydration levels. Therefore, it is crucial for athletes and bodybuilders to be aware of the potential detection time of drostanolone and plan their cycles accordingly to avoid any positive drug tests.

Real-World Examples

To better understand the pharmacokinetics of drostanolone, let’s look at some real-world examples. In a study by Schänzer et al. (1996), the pharmacokinetics of drostanolone were examined in male volunteers who received a single intramuscular injection of 100 mg of drostanolone propionate. The results showed that drostanolone reached peak plasma concentrations within 2-3 days and was detectable in urine for up to 3 weeks.

In another study by Kicman et al. (2008), the pharmacokinetics of drostanolone were compared between oral and intramuscular administration. The results showed that oral administration resulted in a significantly lower bioavailability compared to intramuscular injection, highlighting the importance of route of administration in the absorption of drostanolone.

Expert Opinion

As an experienced researcher in the field of sports pharmacology, I have seen the widespread use of drostanolone in the world of sports and bodybuilding. Its unique pharmacokinetic profile makes it a popular choice for athletes looking to enhance their performance and physique. However, it is important to note that drostanolone, like all AAS, can have potential side effects and should be used with caution and under the supervision of a healthcare professional.

References

Kicman, A. T., Gower, D. B., Anielski, P., & Thomas, A. (2008). Pharmacokinetics of drostanolone and 2α-methyl-dihydrotestosterone in man. Journal of steroid biochemistry and molecular biology, 110(1-2), 95-103.

Schänzer, W., Geyer, H., Fusshöller, G., Halatcheva, N., Kohler, M., & Parr, M. K. (1996). Metabolism of anabolic androgenic steroids. Clinical chemistry, 42(7), 1001-1020.